Hoku Scientific (HOKU) Reports Q4 Adj-Loss of $0.03, Beats by 2c; Doesn't Expect Issuing FY10 Sales Outlook
Hoku Scientific, Inc. (Nasdaq: HOKU) reports Q4 loss of $0.03, ex-items, 2 cents better than the analyst estimate of ($0.05). Revenue for the quarter was $112K, versus the consensus of $300K.
Doesn't expect to issue FY10 sales guidance.
Related Categories
EarningsGuidance
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
